Daré Bioscience, Inc.DARENASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank85
5Y CAGR+10.0%
Studio
Year-over-Year Change

Year-over-year operating income growth rate

5Y CAGR
+10.0%/yr
Long-term compound
Percentile
P85
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
1 yr
Consecutive growthAccelerating
PeriodValue
202424.20%
20231.42%
202219.67%
2021-42.57%
2020-91.02%
201915.03%
2018-51.00%
201769.91%
20160.05%
2015-83.30%